For the Inventor, By the Inventor

Enter assignee name

São Paulo, Brazil

Fundacao Butantan

Calculating rank

USPTO Granted Patents = 13

% Expired Patents = 7.7

EPO Patents = 5

Forward Citations = 1

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Irina Kerkis (5 out of 8 patents)

Cristiane Valverde Wenceslau (2 out of 3 patents)

Neuza Maria Frazatti Gallina (2 out of 2 patents)

4. Denise Vilarinho Tambourgi (2 out of 2 patents)

5. Ana Marisa Chudzinski-Tavassi (2 out of 2 patents)

6. Richard Malley (1 out of 28 patents)

7. Yingjie Lu (1 out of 21 patents)

8. Bárbara Athayde Vaz Galväo Da Silva (1 out of 1 patent)

9. Kerly Fernanda Mesquita Pasqualoto (1 out of 1 patent)

10. Rafael Marques Porto (1 out of 1 patent)

11. Leo Kei Iwai (1 out of 1 patent)

12. Alexandre Kerkis (1 out of 2 patents)

13. Darci Moraes Barros Battesti (1 out of 1 patent)

14. Ronaldo Zucatelli Mendonca (1 out of 1 patent)

15. Durvanei Augusto Maria (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 12480095 - MULTIFUNCTIONAL IMMATURE DENTAL PULP STEM CELLS AND THERAPEUTIC APPLICATIONS (2025-11-25),

2. 12187785 - Recombinant protein and fragments thereof, method for producing said recombinant protein, synthetic gene and use of sculptin or recombinant protein for preparing a medicament or pharmaceutical composition for the prophylaxis and/or treatment of thromboembolic diseases or as a direct and specific inhibitor of thrombin (2025-01-07),

3. 11306290 - Stem cells expressing mesenchymal and neuronal markers, compositions thereof, and methods of preparation thereof (2022-04-19),

4. 11278574 - Use of stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease (2022-03-22),

5. 11207352 - Compositions comprising stem cells expressing mesenchymal and neuronal markers and uses thereof to treat neurological disease (2021-12-28),

6. 11034735 - Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits (2021-06-15),

7. 10869915 - Method for producing embryonic-like stem cells from ticks (acari: ixodidae), composition, uses thereof and diagnostic methods (2020-12-22),

8. 10201600 - Process for preparing an attenuated tetravalent dengue vaccine (2019-02-12),

9. 10081660 - Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptide (2018-09-25),

10. 10004795 - Process for preparing an attenuated tetravalent dengue vaccine (2018-06-26),

11. 9833444 - [object Object] (2017-12-05),

12. 9827299 - Selectively disrupted whole-cell vaccine (2017-11-28),

13. 9512186 - [object Object] (2016-12-06),

Company Overview

Fundação Butantan is a prominent biomedical research institution located in São Paulo, Brazil, specializing in the development of vaccines and biopharmaceuticals. It plays a crucial role in public health by producing immunobiological products, including vaccines for various infectious diseases. The foundation is also engaged in research related to venomous animals, contributing to the development of antivenoms and other therapeutic solutions. Its work significantly impacts both local and global health initiatives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#14 in São Paulo

#51 in Brazil

#45,081 in the World

São Paulo, Brazil

Fundacao Butantan

Forward Citations = 1

34 inventors:

Irina Kerkis (5 out of 8 patents)

Cristiane Valverde Wenceslau (2 out of 3 patents)

Neuza Maria Frazatti Gallina (2 out of 2 patents)

4. Denise Vilarinho Tambourgi (2 out of 2 patents)

5. Ana Marisa Chudzinski-Tavassi (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fundacao Butantan. Retrieved from https://idiyas.com/company/fundacao-butantan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…